Fig. 1: Results as proportions of low and high-risk predictions. | British Journal of Cancer

Fig. 1: Results as proportions of low and high-risk predictions.

From: Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict tests

Fig. 1

Top row displays whole cohort (n = 94) Left: Stratified according to clinical criteria of the MINDACT study (Cardoso et al., NEJM 2016), middle: with EndoPredict, right: with MammaPrint. Bottom row displays clinically high-risk cases. Left: Clinically high-risk cases (n = 43) further stratified with EndoPredict (middle) and MammaPrint (right).

Back to article page